References for Autism and Pervasive Developmental Disorders

Autism and Pervasive Developmental Disorders

Linda J. Lotspeich
Division of Child Psychiatry and Child Development
Department of Psychiatry and Behavioral Sciences
Stanford University School of Medicine
401 Quarry Road
Stanford, California 94305-5719
(650) 723-5511

REFERENCES

1. Ashley CT, Wilkinson KD, Reines D, Warren S T. FMR1 protein: conserved RNP family domains and selective RNA binding. Science 1993;262: 563-566.

2. Abramson RK, Wright HH, Carpenter R, et al. Elevated blood serotonin in autistic probands and their first-degree relatives. J Autism Dev Disord 1989;19:397-407.

3. American-Psychiatric-Association. Diagnostic and Statistical Manual of Mental Disorders, DSM III. Washington, D.C.: American Psychiatric Association,1980.

4. American-Psychiatric-Association. Diagnostic and Statistical Manual of Mental Disorders, DSM III-R. Washington, D.C.: American Psychiatric Association, 1987.

5. American-Psychiatric-Association. Diagnostic and Statistical Manual of Mental Disorders, DSM IV. Washington, D.C.: American Psychiatric Association, 1994.

6. Asperger H. Die 'autistischen Psychopathen' im Kindesalter. Archiv fur Psychiatrie und Nervenkrankheiten 1944;117:76-136.

7. Bailey A, Le couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995;25:63-77.

8. Bailey A, Luthert P, Bolton P, LeCouteur A, Rutter M. Autism and megalencephaly. Lancet 1993;34:1225-1226.

9. Bailey A, Luthert P, Dean A, et al. A clinicaopathological study of autism. Brain 1998;121:889-905.

10. Bailey A, Palferman S, Heavey L, Le Couteur A. Autism: the phenotype in relatives. J Autism Dev Disord 1998;28:369-392.

11. Berkell D, eds. Autism: Identification, education and treatment. Hillsdale: Lawrence Erlbaum Associates, 1992.

12. Brodkin ES, McDougle CJ, Naylor ST, Cohen DJ, Price LH. Clomipramine in adults with pervasive developmental disorders: a prospective open-label investigation. J Child Adolesc Psychopharmacol 1997;7:109-121.

13. Campbell M. Drug treatment of infantile autism: The past decade. In: H. Y. Meltzer, eds. Psychopharmacology: The Third Generation of Progress. New York: Raven Press, 1987;

14. Campbell M, Armenteros JL, Malone RP, Adams PB, Eisenberg ZW, Overall JE. Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study. Am Acad Child Adolesc Psychiatry 1997;36:835-843.

15. Chugani DC, Muzik O, Rothermel R, et al. Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann Neurology 1997;42:666-669.

16. Cook EH, Courchesne RY, Cox NJ, et al. Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. Am J Hum Genet 1998;62:1077-1083.

17. Cook EH, Courchesne RY, Lord C, et al. Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 1997;2:247-250.

18. Cook EH, Leventhal BL, Hellar W, Metz J, Wainwright M, Freedman DX. Autistic children and their first-degree relatives: Relationships between serotonin and norepinephrine levels and intelligence. J Neuropsychiatry Clin Neurosci 1990;2:268-274.

19. Cook EH, Rowlet R, Jaselskis C, Leventhal BL. Fluoxetine treatment of children and adults with autistic disorder and mental retardation. J Am Acad Child Adolesc Psychiatry 1992;4:739-345.

20. Courchesne E, Press GA, Yeung-Courchesne R. Parietal lobe abnormalities detected with MR in patients with infantile autism. Am J Roentgenol 1993;160:387-393.

21. Courchesne R, Saitoh O, Yeung-Courchesne R, et al. Abnormality of cerebellar vermian lobules VI and VII in patients with infantile autism: identification of hypoplastic and hyperplastic subgroups with MR imaging. Am J Roentgenol 1994;162:123-130.

22. Courchesne R, Townsend J, Saitoh O. The brain in infantile autism: Posterior fossa structures are abnormal. Neurology 1994;44:214-223.

23. DeLong GR, Teague LA, McSwain-Kamran M. Effects of fluoxetine treatment in young children with idiopathic autism. Dev Med Child Neurol 1998;40:551-562.

24. Dykens EM, Volkmar FR. Medical conditions associated with autism. In Cohen DJ, Volkmar FR, eds. Handbook of autism and pervasive developmental disorders (2nd ed). New York: Wiley, 1997;388-407.

25. Egaas B, Courchesne E, Saitoh O. Reduced size of corpus callosum in autism. Arch Neurol 1995;52:794-801.

26. Feinstein C, Reiss AL. Autism: the point of view from fragile X studies. J Autism Dev Disord 1998;28:393-405.

27. Filipek PA. Quantitative magnetic resonance imaging in autism: the cerebellar vermis. Cur Opinion in Neurol 1995;8:134-138.

28. Gaffney GR, Kuperman S, Tsai LY, Minchin S. Forebrain structure in infantile autism. J Am Acad Child Adolesc Psychiatry 1989;28:534-537.

29. Gillberg C. Endogenous opioids and opiate antagonists in autism: brief review of empirical findings and implications for clinicians. Dev Med Child Neurol 1995;37:239-245.

30. Gillberg C, Steffenburg S, Wahlstrom J, et al. Autism associated with marker chromosome. J Am Acad Child Adolesc Psychiatry 1991;30:489-494

31. Gillberg C, Terenius L, Lonnerholm G. Endorphin activity in childhood psychosis. Arch Gen Psychiatry 1985;42:780-783.

32. Gordon CT, State RC, Nelson JE, Hamburger SD, Rapoport JL. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry 1993;50:441-447.

33. Hagberg G, Aicardi F, Dias K, Ramos O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: Report of 35 cases. Ann Neurol 1983;14:471-470.

34. Hagerman RJ, Crosister AJ, eds. Epidemiology, Fragile X syndrome (2nd ed). Baltimore: Johns Hopkins University Press, 1991.

35. Hallmayer J, Pintoda E, Lotspeich L, et al. Molecular analysis and test of linkage between the FMR-1 gene and infantile autism in multiplex families. Amer J Hum Genet 1994;55:951-959.

36. Haznedar MM, Buchsbaum MS, Metzger M, Solimando A, Spiegel-Cohen J, Hollander E. Anterior cingulate gyrus volume and glucose metabolism in autistic disorder. Am J Psychiatry 1997;154:10471050.

37. Hellings JA, Kelley LA, Gabrielli WF, Kilgore E, Shah P. Sertraline response in adults with mental retardation and autistic disorder. J Clin Psychiatry 1996;57:333-336.

38. International Molecular Genetic Study of Autism Consortium. A full genome screen for autism with evidence for linkage to a region on chromosome 7q. Hum Mole Genet 1998;7:571-578.

39. Jorde LB, Mason-Brothers A, Waldmann R, et al. The UCLA-University of Utah epidemiologic survey of autism: Genealogical analysis of familial aggregation. Am J Med Genet 1990;36:85-88.

40. Kanner L. Autistic disturbances of affective contact. Nerv Child 1943;2:217-250.

41. Kates WR, Mostofsky SH, Zimmerman AW, et al. Neuroanatomical and neurocognitive differences in a pair of monozygous twins discordant for strictly defined autism. Ann Neurol 1998;43:782-791.

42. Kemper T, Bauman M. Neuropathology of infantile autism. J Neuropath Exp Neurol 1998;57:645-652.

43. Klauck SM, Poustka F, Benner A, Klaus-Peter L, Poustka A. Serotonin transporter (5-HTT) gene variants associated with autism? Hum Mol Genet 1997;6:2233-2238.

44. Klin A, Volkmar FR. Asperger’s Disorder. In Cohen DJ, Volkmar FR, eds. Handbook of autism and pervasive developmental disorders (2nd ed). New York: Wiley, 1997;94-122.

45. Kuperman S, Beeghly JH, Burns TL, Tsai LY. Serotonin relationships of autistic probands and their first-degree relatives. J Am Acad Child Adolesc Psychiatry 1985;24:186-190.

46. Lotspeich LJ. Autism and pervasive developmental disorders. In: Bloom FE, & Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, 1995;1655-1663.

47. Lotspeich LJ, Ciaranello RD. The neurobiology and genetics of infantile autism. In: R. Bradley and R. Harris, eds. International Review of Neurobiology. San Diego: Academic Press, 1993:87-129.

48. McBride PA, Anderson GM, Hertzig ME, et al. Serotonergic responsivity in male young adults with autistic disorder. Arch Gen Psychiatry 1989;46:213-221.

49. McDougle CJ. Psychopharmacology. In Cohen DJ, Volkmar FR, eds. Handbook of autism and pervasive developmental disorders (2nd ed). New York: Wiley, 1997;707-729.

50. McDougle CJ, Holmes JP, Carlson DC, Pelton GH, Cohen DJ, Price LH. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch Gen Psychiatry 1998;55:633-641.

51. McDougle CJ, Naylor ST, Cohen DJ, Volkmar FR, Heninger GR, Price LH. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 1996;53:1001-1008.

52. Minshew NJ, Sweeney JA, Bauman ML. Neurological aspects of autism. In Cohen DJ, Volkmar FR, eds. Handbook of autism and pervasive developmental disorders (2nd ed). New York: Wiley, 1997;344-369.

53. Oberlé I, Rousseau F, Heitz D, et al. Instability of a 550-Base Pair DNA Segment and Abnormal Methylation in Fragile X Syndrome. Science 1991;252:1097-1102.

54. Panksepp J, Sahley TL. Possible brain opioid involvement in disrupted social intent and language development in autism. In: E. Schopler and G. B. Mesibov, eds. Neurobiological Issues in Autism. New York: Plenum Press, 1987;357-372.

55. Pericak-Vance MA, Wolpert CM, Menold MM, et al. Linkage evidence supports the involvement of chromosome 15 in autistic disorder. Am J Hum Genet Supplement A40:208.

56. Piven J, Tsai G, Nehme E, Coyle JT. Platelet serotonin, a possible marker for familial autism. J Autism Dev Disord 1991;21:51-59.

57. Piven J, Arndt S, Bailey J, Andreasen NC. Regional brain enlargement in autism: a magnetic resonance imaging study. J Am Acad Child Adolesc Psychiatry 1995;35:530-536.

58. Piven J, Arndt S, Bailey J, Havercamp S, Andreasen NC, Palmer P. An MRI study of brain size in autism. Am J Psychiatry 1995;152:1145-1148.

59. Piven J, Bailey J, Ranson BJ, Arndt S. An MRI study of the corpus callosum in autism. Am J Psychiatry 1997;154:1051-1056.

60. Piven J, Bailey J, Ranson B, Arndt S. No difference in hippocampus volume detected on magnetic resonance imaging in autistic individuals. J Autism Dev Disord 1998;28:105-110.

61. Piven J, Saliba K, Bailey J, Arndt S. An MRI study of autism: the cerebellum revisited. Am Acad Neurol 1997;49:546-551.

62. Rett A. Uber ein eigenartiges hirmatrophisches syndrom bei hyperammoniamie in kindesalter. Wien MedWochenschr 1966;116:723-738.

63. Ritvo ER, Freeman BJ. National society for autistic children definition of the syndrome of autism. J Autism Child Schizophr 1978;8:162-167.

64. Ritvo RE, Spence MA, Freeman BJ, Mason-Brothers A, Mo A, Marazita ML. Evidence for autosomal recessive inheritance in 46 families with multiple incidences of autism. Am J Psychiatry 1985;142:187-192.

65. Ross DL, Klykylo WM, Hitzemann R. Reduction of elevated CSF beta-endorphin by fenfluramine in infantile autism. Pediatr Neurol 1987;3:83-86.

66. Rutter M, Hersov R, eds. Child Psychiatry: Modern approaches. Oxford: Blackwell Scientific, 1977.

67. Saitoh O, Courchesne E, Egaas B, Lincoln AJ, Schreibman L. Cross-sectional area of the posterior hippocampus in autistic patients with cerebellar and corpus callosum abnormalities. Neurology 1995;45:317-324.

68. Sanchez LE, Campbell M, Small AM, Cueva JE, Armenteros JL, Adams PB. A pilot study of clomipramine in young autistic children. J Am Acad Child Adolesc Psychiatry 1996;35:534-544.

69. Sandman CA. The opiate hypothesis in autism and self-injury. J Child Adolesc Psychopharmacol 1990/1991;1:237-248.

70. Sherman SL, Jacobs PA, Morton NE, et al. Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet 1985;68:289-299.

71. Smalley SL, Asarnow RF, Spence A. Autism and genetics, a decade of research. Arch Gen Psychiatry 1988;45:953-961.

72. Spence MA, Ritvo ER, Marazita ML, Funderburk SJ, Sparkes RS, Freeman BJ. Gene mapping studies with the syndrome of autism. Beh Genet 1985;15:1-13.

73. Steingard RJ, Zimnitzky B, DeMaso DR, Bauman ML, Bucci JP. Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder. J Child Adolesc Psychopharmacol 1997;7:9-15.

74. Szatmari P, Jones MB, Zaigenbaum L, MacLean JE. Genetics of autism: overview and new directions. J Autism Dev Disord 1998;28:351-368.

75. Tanguay PE, Robertson J, Derrick A. A dimensional classification of autism spectrum disorder by social communication domains. J Am Acad Child Adolesc Psychiatry 1998;37:271-277.

76. Van Acker R. Rett’s syndrome: a pervasive developmental disorder. In Cohen DJ, Volkmar FR, eds. Handbook of autism and pervasive developmental disorders (2nd ed). New York: Wiley, 1997;60-93.

77. Wing L. Asperger's syndrome: A clinical account. Psychol Med 1981;11:115-129.

78. Witt-Engerstrom I, Gillberg C. Rett syndrome in Sweden. J Autism Dev Disord 1987;17:149-150.

79. World-Health-Organization. ICD-9. International classification of diseases, 9th ed. Geneva:Author,1977.

80. World-Health-Organization. ICD-10. Classification of mental and behavioral disorders. Diagnostic Criteria for Research. Geneva:Author,1993.

81. Xiang F, Zhang Z, Clarke A, et al. Chromosome mapping of Rett syndrome: a likely candidate region on the telomere of Xq. J. Med. Genet. 1998;35: 297-300.

82. Young JG, Leven LI, Newcorn JH, Knott PJ. Genetic and neurobiological approaches to the pathophysiology of autism and the pervasive developmental disorders. In: H. Y. Meltzer, eds. Psychopharmacology: The third generation of progress. New York: Raven Press, 1987;825-836.

Return to Chapter

published 2000